Rising Pharma Holding, Inc. 2025-10-22 Health serious FDA
Health · FDA · Recall #FDA-D-0029-2026
Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only,… Recall
Issued October 22, 2025 · Rising Pharma Holding, Inc.
In October 2025, Rising Pharma Holding, Inc. recalled the Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).
What you should do
- 1 Stop using Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Rising Pharma Holding, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Rising Pharma Holding, Inc.
- Category
- Health
- Recall date
- October 22, 2025
- Units affected
- Not reported
- Sold at
- Distributed Nationwide in the USA
- Recall number
- FDA-D-0029-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Rising Pharma Holding, Inc. has 3 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.